NCT02825758

Brief Summary

A study to evaluate the acceptability of ZestiVits; a new vitamin, mineral and trace element supplement for children aged 11 years and over and adults on a ketogenic or restricted therapeutic diet with regard to product tolerance, palatability and compliance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2017

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 7, 2016

Completed
8 months until next milestone

Study Start

First participant enrolled

February 17, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2018

Completed
Last Updated

February 16, 2024

Status Verified

February 1, 2024

Enrollment Period

1.5 years

First QC Date

June 24, 2016

Last Update Submit

February 15, 2024

Conditions

Keywords

Micronutrientsrestrictedketogenicdietacceptability

Outcome Measures

Primary Outcomes (4)

  • Palatability via qualitative assessments from a subject questionnaire

    Qualitative outcome measures will be described in a narrative summarising the study outcomes

    7 days

  • Gastrointestinal tolerance via qualitative assessments from a subject questionnaire

    Qualitative outcome measures will be described in a narrative summarising the study outcomes

    7 days

  • Patient compliance via qualitative assessments from a subject questionnaire

    Qualitative outcome measures will be described in a narrative summarising the study outcomes

    7 days

  • Ease of use of product via qualitative assessments from a subject questionnaire

    Qualitative outcome measures will be described in a narrative summarising the study outcomes

    7 days

Study Arms (1)

ZestiVits

EXPERIMENTAL

Supplement for use in ketogenic and restricted therapeutic diets, from the age of 11. Daily use for 7 days. Daily intake level for each subject will be determined and prescribed by a dietitian.

Dietary Supplement: ZestiVits

Interventions

ZestiVitsDIETARY_SUPPLEMENT

The study product is a low-carbohydrate, orange flavour, vitamin, mineral and trace element (micronutrient) supplement for use in ketogenic and restricted therapeutic diets, for children aged from 11 years of age and adults. The recommended dosage of the study product for each subject will be determined and prescribed by a dietitian. This will be based on individual requirements for micronutrient supplementation.

ZestiVits

Eligibility Criteria

Age11 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of condition requiring a ketogenic or restrictive therapeutic diet
  • On a ketogenic or restricted therapeutic diet with good compliance
  • Aged 11 years and over
  • Has a requirement for a micronutrient supplement
  • Written informed consent by subject or parent/carer

You may not qualify if:

  • Participants aged less than 11 years
  • Use of additional micronutrient supplements during the study period unless clinically indicated and prescribed by the investigator (must be recorded in patient case record file)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Bristol Royal Hospital for Children

Bristol, Avon, BS2 8BJ, United Kingdom

Location

Salford Royal NHS Foundation Trust

Salford, Greater Manchester, M6 8HD, United Kingdom

Location

Leeds Children's Hospital

Leeds, West Yorkshire, LS1 3EX, United Kingdom

Location

Study Officials

  • Gisela Wilcox

    Northern Care Alliance NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2016

First Posted

July 7, 2016

Study Start

February 17, 2017

Primary Completion

August 31, 2018

Study Completion

August 31, 2018

Last Updated

February 16, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations